Accéder au contenu
Merck

793620

Lithium chloride

anhydrous, free-flowing, Redi-Dri™, ReagentPlus®, 99%

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

A propos de cet article

Formule linéaire :
LiCl
Numéro CAS:
7447-41-8
Poids moléculaire :
42.39
NACRES:
NA.21
PubChem Substance ID:
329768091
UNSPSC Code:
12352302
EC Number:
231-212-3
MDL number:
MFCD00011078
Assay:
99%
Grade:
anhydrous
Form:
powder or crystals

Principaux documents

Voir toute la documentation
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

InChI key

KWGKDLIKAYFUFQ-UHFFFAOYSA-M

InChI

1S/ClH.Li/h1H;/q;+1/p-1

SMILES string

[Li+].[Cl-]

grade

anhydrous

product line

ReagentPlus®, Redi-Dri™

assay

99%

form

powder or crystals

quality

free-flowing

pH

6

mp

605 °C (lit.)

Quality Level

100

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

General description

Redi-Dri™ technology eliminates clumping and the need for complicated procedures to keep your salts free-flowing. Keeping your salts dry helps improve your results by giving accurate measurements and easier-to-handle salts and buffers. Rather than drying your salts in an oven or desiccator or breaking them apart manually, Redi-Dri™ ensures that your salts will remain easy-to-use for months without worrying about anti-caking agents. Even after repeated openings you can be assured that your results are always accurate. Redi-Dri™ saves you time, energy and money by keeping your salts usable for longer!

Application

Lithium chloride can be used as a catalyst in the solvent-free:
  • Cyanosilylation of aldehydes and ketones with cyanotrialkylsilanes to give silylated cyanohydrins.
  • Microwave-assisted Claisen-Schmidt condensation to prepare α, β-unsaturated ketones.
It can also be used as:
  • An additive in the Pd-catalyzed Stille coupling of aryl iodides with arylstannanes to synthesize corresponding biphenyls.
  • A catalyst for the chemo- and regioselective demethylation of aryl methyl ethers to corresponding phenol products.

Features and Benefits

  • Increased efficiency – Eliminate time and effort of loosening hardened powders
  • Safety – Avoid risks of using tools of force to break up clumps
  • Economy – Faster preparation and solvation increase productivity and reduce costs
  • Assured quality – Excellent, expert-tested quality with no anti-caking agents
  • Flexible volumes – Available from research amounts to scale-up quantities

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2

Classe de stockage

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
MKCZ8941
0000494688
0000494688
MKCX9799
MKCX6999

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

  1. How does Redi-Dri™ help keep salts and buffers free-flowing?

    Redi-Dri™ products are specially handled and the bottle is specially designed to ensure that the product will remain dry without adding impurities or additives to the product. Ensuring that you receive the highest quality material that is easy to handle.

  2. Are there any special storage conditions that must be maintained?

    No, Redi-Dri™ products can be stored under the same conditions as the equivalent non-Redi-Dri™ products.

  3. How long will material remain free-flowing after it is opened?

    While the exact amount of time your material will remain free-flowing can vary, this largely depends on the ambient storage conditions and how many times it is opened.

Giovanna Cutrone et al.
Carbohydrate polymers, 223, 115085-115085 (2019-08-21)
Nanoparticles made of metal-organic frameworks (nanoMOFs) are becoming of increasing interest as drug carriers. However, engineered coatings such as poly(ethylene glycol) (PEG) based ones are required to prevent nanoMOFs recognition and clearance by the innate immune system, a prerequisite for
Alessandro Di Maio et al.
EvoDevo, 6, 17-17 (2015-07-15)
Wnt signaling is one of the earliest and most highly conserved regulatory pathways for the establishment of the body axes during regeneration and early development. In regeneration, body axes determination occurs independently of tissue rearrangement and early developmental cues. Modulation
Na An et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(40), 14325-14331 (2014-09-17)
Human telomeric DNA consists of tandem repeats of the sequence 5'-TTAGGG-3' that can fold into various G-quadruplexes, including the hybrid, basket, and propeller folds. In this report, we demonstrate use of the α-hemolysin ion channel to analyze these subtle topological
Ted M Hsu et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(2), 327-337 (2014-07-19)
Glucagon-like peptide-1 (GLP-1) is produced in the small intestines and in nucleus tractus solitarius (NTS) neurons. Activation of central GLP-1 receptors (GLP-1Rs) reduces feeding and body weight. The neural circuits mediating these effects are only partially understood. Here we investigate
Hector Vargas-Perez et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 34(23), 7899-7909 (2014-06-06)
Drug administration to avoid unpleasant drug withdrawal symptoms has been hypothesized to be a crucial factor that leads to compulsive drug-taking behavior. However, the neural relationship between the aversive motivational state produced by drug withdrawal and the development of the
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique